Central nervous system tuberculosis in Western Sydney: a 10‐year retrospective cohort study
Internal Medicine Journal · 2025
DOI: 10.1111/imj.70017 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Internal Medicine Journal, 2025. Verfasst von Hayden Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Department, Blacktown Hospital, Blacktown, New South Wales, Australia. Hauptthemen laut MEDLINE: Tuberculosis, Central Nervous System. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Central nervous system tuberculosis (CNS‐TB) is a rare complication of tuberculosis. There is a lack of data surrounding investigation and management of this in Australia.
Aim
To review CNS‐TB cases in Western Sydney, Australia, and understand the epidemiology, investigation, diagnosis, management and outcomes in a low‐prevalence setting.
Methods
Retrospective cohort study of all CNS‐TB patients managed in Western Sydney from 2013 to 2022. Demographics, risk factors, clinical presentation, investigations and management were reviewed. Clinical outcomes like hospital length‐of‐stay, adverse drug reactions, paradoxical reactions, functional disability and treatment outcomes, including cure, treatment failure, loss to follow‐up and death, were also measured.
Results
Thirty‐nine CNS‐TB cases were identified, with 16 (41%) confirmed by nucleic acid amplification test or culture of CNS specimens and 23 (59%) diagnosed presumptively without CNS microbiological confirmation. The median age was 32 years. Thirty‐seven (95%) were overseas‐born; 27 (69%) had no comorbidities. Presenting symptoms included fever (82%), headache (64%) and weight loss (51%). Twenty‐five (64%) used fluoroquinolones and nine (23%) used high‐dose rifampicin. Steroids were used in all patients. Six (15%) were prescribed aspirin for primary stroke prevention. Twenty‐eight (73%) completed treatment, with one requiring re‐treatment for presumed treatment failure. Six (15%) were lost to follow‐up, and five (13%) died during their treatment course. Twenty‐one (54%) experienced an adverse drug reaction.
Conclusion
Tuberculosis is an ongoing public health issue in Australia, with CNS‐TB being its most devastating form, and all clinicians to be aware of this rare complication. The efficacy of newer treatment options requires further study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infectious Diseases Department, Blacktown Hospital, Blacktown, New South Wales, Australia.
- School of Medicine, Western Sydney University, Blacktown, New South Wales, Australia.
- Faculty of Health and Medicine, University of Sydney, Sydney, New South Wales, Australia.
- NSW Tuberculosis Program, Health Protection New South Wales, Sydney, New South Wales, Australia.
- Centre for Infectious Diseases and Microbiology, Westmead Hospital, Sydney, New South Wales, Australia.
ORCID-Profile: Hayden Zhang
Zitieren
APA
Zhang, H., Hasan, T., Dotel, R., Ulbricht, E., Gilroy, N., & Maddocks, S. (2025). Central nervous system tuberculosis in Western Sydney: a 10‐year retrospective cohort study. Internal Medicine Journal. https://doi.org/10.1111/imj.70017
Vancouver
Zhang H, Hasan T, Dotel R, Ulbricht E, Gilroy N, Maddocks S. Central nervous system tuberculosis in Western Sydney: a 10‐year retrospective cohort study. Internal Medicine Journal. 2025. doi:10.1111/imj.70017
BibTeX
@article{Zhang2025,
author = {Zhang, Hayden and Hasan, Tasnim and Dotel, Ravindra and Ulbricht, Evan and Gilroy, Nicole and Maddocks, Susan},
title = {Central nervous system tuberculosis in Western Sydney: a 10‐year retrospective cohort study},
journal = {Internal Medicine Journal},
year = {2025},
doi = {10.1111/imj.70017}
}
EUVIMED